Protein kinase C-δ isoform mediates lysosome labilization in DNA damage-induced apoptosis

International Journal of Oncology

Volumn 38, Issue 2, 2011, Pages 313-324

  Parent, Nicolas ^a   Scherer, Max ^b   Liebisch, Gerhard ^b   Schmitz, Gerd ^b   Bertrand, Richard ^a,c  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Apoptosis; Camptothecin; Electrospray ionization tandem mass spectrometry; Lysosome; Protein kinase C ; Sphingolipids

Indexed keywords

CAMPTOTHECIN DERIVATIVE; CASPASE; CATHEPSIN; CERAMIDE; PROTEIN KINASE C DELTA; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LYMPHOMA CELL; LYSOSOME MEMBRANE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 78651253458     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2010.881     Document Type: Article

References (85)

1. Ferri KF and Kroemer G: Organelle-specific initiation of cell death pathways. Nat Cell Biol 3: E255-E263, 2001.
2. 2 is a consequence of lysosomal rupture. Biochem J 356: 459-555, 2001.
3. Roberg K and Ollinger K: Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 152: 1151-1156, 1998.
4. 2 provoke lysosomal damage in human astrocytoma D384 cells followed by apoptosis. Free Radic Biol Med 30: 1347-1356, 2001.
5. Brunk UT: Lysosomotropic detergents induce time- and dose-dependent apoptosis/necrosis in cultured cells. Redox Rep 5: 87-88, 2000.
6. Uchimoto T, Nohara H, Kamehara R, Iwamura M, Watanabe N and Kobayashi Y: Mechanism of apoptosis induced by a lysosomotropic agent, L-Leucyl-L-Leucine methyl ester. Apoptosis 4: 357-362, 1999.
7. Li W, Yuan X, Nordgren G, Dalen H, Dubowchik GM, Firestone RA and Brunk UT: Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett 470: 35-39, 2000.
8. Van Nierop K, Muller FJ, Stap J, van Noorden CJ, van Eijk M and de Groot C: Lysosomal destabilization contributes to apoptosis of germinal center B-lymphocytes. J Histochem Cytochem 54: 1425-1435, 2006.
9. Brunk UT, Dalen H, Roberg K and Hellquist HB: Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic Biol Med 23: 616-626, 1997.
10. Kessel D, Luo Y, Mathieu P and Reiners JJJ: Determinants of the apoptotic response to lysosomal photodamage. Photochem Photobiol 71: 196-200, 2000
11. Nagata S, Obana A, Gohto Y and Nakajima S: Necrotic and apoptotic cell death of human malignant melanoma cells following photodynamic therapy using an amphiphilic photosensitizer, ATX-S10(Na). Lasers Surg Med 33: 64-70, 2003.
12. Ichinose S, Usuda J, Hirata T, Inoue T, Ohtani K, Maehara S, Kubota M, Imai K, Tsunoda Y, Kuroiwa Y, Yamada K, Tsutsui H, Furukawa K, Okunaka T, Oleinick NL and Kato H: Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na). Int J Oncol 29: 349-355, 2006.
13. Brunk UT and Svensson I: Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Rep 4: 3-11, 1999.
14. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH and Gores GJ: Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106: 1127-1137, 2000.
15. Gyrd-Hansen M, Farkas T, Fehrenbacher N, Bastholm L, Hoyer-Hansen M, Elling F, Wallach D, Flavell R, Kroemer G, Nylandsted J and Jäättela M: Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9. Mol Cell Biol 26: 7880-7891, 2006.
16. Kågedal K, Zhao M, Svensson I and Brunk UT: Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 359: 335-343, 2001.
17. Heinrich M, Wickel M, Schneider-Brachert W, Sandberg C, Gahr J, Schwandner R, Weber T, Saftig P, Peters C, Brunner J, Krönke M and Schütze S: Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 18: 5252-5263, 1999.
18. Paris C, Bertoglio J and Bréard J: Lysosomal and mitochondrial pathways in miltefosine-induced apoptosis in U937 cells. Apoptosis 12: 1257-1267, 2007.
19. Paquet C, Sané AT, Beauchemin M and Bertrand R: Caspase- and mitochondrial dysfunction-dependent mechanisms of lysosomal leakage and cathepsin B activation in DNA damageinduced apoptosis. Leukemia 19: 784-791, 2005.
20. Hishita T, Tada-Oikawa T, Tohyama K, Miura Y, Nishihara T, Tohyama Y, Yoshida Y, Uchiyama T and Kawanishi S: Caspase-3 activation by lysosomal enzymes in cytochrome c-independent apoptosis in myelodysplastic syndrome-derived cell line P39. Cancer Res 61: 2878-2884, 2001.
21. Broker LE, Huisman C, Span SW, Rodriguez JA, Kruyt FA and Giaccone G: Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res 64: 27-30, 2004.
22. Groth-Pedersen L, Ostenfeld MS, Hoyer-Hansen M, Nylandsted J and Jäättela M: Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res 67: 2217-2225, 2007.
23. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, Ojcius DM, Jäättela M and Kroemer G: Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 197: 1323-1334, 2003.
24. Zang Y, Beard RL, Chandraratna RA and Kang JX: Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Differ 8: 477-485, 2001.
25. Yu H, Zhou Y, Lind SE and Ding WQ: Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J 417: 133-139, 2009.
26. Thibodeau MS, Giardina C, Knecht DA, Helble J and Hubbard AK: Silica-induced apoptosis in mouse alveolar macrophages is initiated by lysosomal enzyme activity. Toxicol Sci 80: 34-48, 2004.
27. Brunk UT, Neuzil J and Eaton JW: Lysosomal involvement in apoptosis. Redox Rep 6: 91-97, 2001.
28. Turk B, Stoka V, Rozman-Pungercar J, Cirman T, Droga-Mazovec G, Oreic K and Turk V: Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 383: 1035-1044, 2002.
29. Guicciardi ME, Leist M and Gores GJ: Lysosomes in cell death. Oncogene 23: 2881-2890, 2004.
30. Leist M and Jäättela M: Triggering of apoptosis by cathepsins. Cell Death Differ 8: 324-326, 2001.
31. Terman A, Kurz T, Gustafsson B and Brunk UT: Lysosomal labilization. IUBMB Life 58: 531-539, 2006.
32. Siskind LJ, Fluss S, Bui M and Colombini M: Sphingosine forms channels in membranes that differ greatly from those formed by ceramide. J Bioenerg Biomembr 37: 227-236, 2005.
33. Hu JS, Li YB, Wang JW, Sun L and Zhang GJ: Mechanism of lysophosphatidylcholine-induced lysosome destabilization. J Membr Biol 215: 27-35, 2007.
34. Kågedal K, Johansson AC, Johansson U, Heimlich G, Roberg K, Wang NS, Jurgensmeier JM and Ollinger K: Lysosomal membrane permeabilization during apoptosis-involvement of Bax? Int J Exp Pathol 86: 309-321, 2005.
35. Zhao M, Brunk UT and Eaton JW: Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Lett 509: 399-404, 2001.
36. Mukherjee AK, Ghosal SK and Maity CR: Lysosomal membrane stabilization by a tocopherol against the damaging action of Vipera russelli venom phospholipase A2. Cell Mol Life Sci 53: 152-155, 1997.
37. Hiraoka M, Abe A, Lu Y, Yang K, Han X, Gross RW and Shayman JA: Lysosomal phospholipase A2 and phospholipidosis. Mol Cell Biol 26: 6139-6148, 2006.
38. Wang JW, Sun L, Hu JS, Li YB and Zhang GJ: Effects of phospholipase A2 on the lysosomal ion permeability and osmotic sensitivity. Chem Phys Lipids 144: 117-126, 2006.
39. Wang X, Wang LL and Zhang GJ: Guanosine 5′-[gammathio] triphosphate-mediated activation of cytosol phospholipase C caused lysosomal destabilization. J Membr Biol 211: 55-63, 2006.
40. Zhao HF, Wang X and Zhang GJ: Lysosome destabilization by cytosolic extracts, putative involvement of Ca(2+)/phospholipase C. FEBS Lett 579: 1551-1556, 2005.
41. Li N, Zheng Y, Chen W, Wang C, Liu X, He W, Xu H and Cao X: Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis. Cancer Res 67: 11176-11185, 2007.
42. Nylandsted J, Gyrd-Hansen M, Danielewicz A, Fehrenbacher N, Lademann U, Hoyer-Hansen M, Weber E, Multhoff G, Rohde M and Jäättela M: Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 200: 425-435, 2004. (Pubitemid 39121900)
43. Zhao M, Eaton JW and Brunk UT: Bcl-2 phosphorylation is required for inhibition of oxidative stress-induced lysosomal leak and ensuing apoptosis. FEBS Lett 509: 405-412, 2001.
44. Schmitt E, Cimoli G, Steyaert A and Bertrand R: Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities. Exp Cell Res 240: 107-121, 1998.
45. Sané AT and Bertrand R: Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities. Cancer Res 58: 3066-3072, 1998.
46. Parent N, Winstall E, Beauchemin M, Paquet C, Poirier GG and Bertrand R: Proteomic analysis of enriched lysosomes at early phase of camptothecin-induced apoptosis in human U-937 cells. J Proteomics 72: 960-973, 2009.
47. Fukumoto S, Nishizawa Y, Hosoi M, Koyama H, Yamakawa K, Ohno S and Morii H: Protein kinase Cδ inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J Biol Chem 272: 13816-13822, 1997.
48. Oh YT, Chun KH, Oh JI, Park JA, Kim YU and Lee SK: PKC-δ modulates p21WAF1/CIP1 ability to bind to Cdk2 during TNF alpha-induced apoptosis. Biochem Biophys Res Commun 339: 1138-1149, 2006.
49. Brodie C and Blumberg PM: Regulation of cell apoptosis by protein kinase cδ. Apoptosis 8: 19-27, 2003.
50. Reyland ME: Protein kinase Cδ and apoptosis. Biochem Soc Trans 35: 1001-1004, 2007.
51. Reyland ME: Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci 14: 2386-2399, 2009.
52. Yoshida K: PKC delta signaling: mechanisms of DNA damage response and apoptosis. Cell Signal 19: 892-901, 2007.
53. Gomel R, Xiang C, Finniss S, Lee HK, Lu W, Okhrimenko H and Brodie C: The localization of protein kinase C-delta in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways. Mol Cancer Res 5: 627-639, 2007.
54. Zeidan YH and Hannun YA: Activation of acid sphingomyelinase by protein kinase C delta-mediated phosphorylation. J Biol Chem 282: 11549-11561, 2007.
55. Zeidan YH, Wu BX, Jenkins RW, Obeid LM and Hannun YA: A novel role for protein kinase C delta-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury. FASEB J 22: 183-193, 2008.
56. Torgersen ML, Walchli S, Grimmer S, Skanland SS and Sandvig K: Protein kinase C delta is activated by Shiga toxin and regulates its transport. J Biol Chem 282: 16317-16328, 2007.
57. Labeed FH, Coley HM and Hughes MP: Differences in the biophysical properties of membrane and cytoplasm of apoptotic cells revealed using dielectrophoresis. Biochim Biophys Acta 1760: 922-929, 2006.
58. Bertrand R, Sarang M, Jenkin J, Kerrigan D and Pommier Y: Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res 51: 6280-6285, 1991.
59. Storrie B and Madden EA: Isolation of subcellular organelles. Methods Enzymol 182: 203-225, 1990.
60. Nishikawa K, Toker A, Johannes FJ, Songyang Z and Cantley LC: Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem 272: 952-960, 1997.
61. Hojjati WR and Jiang XC: Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J Lipid Res 47: 673-676, 2006.
62. Binder M, Liebisch G, Langmann T and Schmitz G: Metabolic profiling of glycerophospholipid synthesis in fibroblasts loaded with free cholesterol and modified low density lipoproteins. J Biol Chem 281: 21869-21877, 2006.
63. Wiesner P, Leidl K, Boettcher A, Schmitz G and Liebisch G: Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. J Lipid Res 50: 574-585, 2009.
64. Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A and Schwudke D: Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49: 1137-1146, 2008.
65. Liebisch G, Drobnik W, Reil M, Trumbach B, Arnecke R, Olgemoller B, Roscher A and Schmitz G: Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS). J Lipid Res 40: 1539-1546, 1999.
66. Scherer M, Schmitz G and Liebisch G: High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography- tandem mass spectrometry. Clin Chem 55: 1218-1222, 2009.
67. Goldstein JC, Waterhouse NJ, Juin P, Evan GI and Green DR: The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat Cell Biol 2: 156-162, 2000.
68. Gschwendt M, Müller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G and Marks F: Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98, 1994.
69. Albouz S, Le Saux F, Wenger D, Hauw JJ and Baumann N: Modifications of sphingomyelin and phosphatidylcholine metabolism by tricyclic antidepressants and phenothiazines. Life Science 38: 357-363, 1986.
70. Merrill AH, van Echten G, Wang E and Sandhoff K: Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol Chem 268: 27299-27306, 1993.
71. Khwaja A and Tatton L: Caspase-mediated proteolysis and activation of protein kinase C delta plays a central role in neutrophil apoptosis. Blood 94: 291-301, 1999.
72. Song MG, Gao SM, Du KM, Xu M, Yu Y, Zhou YH, Wang Q, Chen Z, Zhu YS and Chen GQ: Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase C delta-dependent mechanisms. Blood 105: 3714-3721, 2005.
73. Pettus BJ, Chalfant CE and Hannun YA: Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585: 114-125, 2002.
74. Thomas HE, Darwiche R, Corbett JA and Kay TW: Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. J Immunol 163: 1562-1569, 1999.
75. Chatelut M, Leruth M, Harzer K, Daga A, Marchesini S, Gatt S, Salvayre R, Courtoy P and Levade T: Natural ceramide is unable to escape the lysosome, in contrast to a fuorescent analogue. FEBS Lett 426: 102-106, 1998.
76. Siskind LJ, Kolesnick RN and Colombini M: Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J Biol Chem 277: 26796-26803, 2002.
77. Ogretmen B and Hannun YA: Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4: 604-616, 2004.
78. Stoffel W: Functional analysis of acid and neutral sphingomyelinases in vitro and in vivo. Chem Phys Lipids 102: 107-121, 1999.
79. He X, Okino N, Dhami R, Dagan A, Gatt S, Schulze H, Sandhoff K and Schuchman EH: Purification and characterization of recombinant human acid ceramidase. J Biol Chem 278: 32978-32986, 2003.
80. Sané AT and Bertrand R: Caspase inhibition in camptothec-intreated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death. Cancer Res 59: 3565-3569, 1999.
81. Li W, Yuan X, Ivanov S, Tracey KJ, Eaton JW and Brunk UT: 3-Aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin. Biochem J 371: 429-436, 2003.
82. Ostenfeld MS, Fehrenbacher N, Hoyer-Hansen M, Thomsen C, Farkas T and Jaattela M: Effective tumor cell death by σ-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. Cancer Res 65: 8975-8983, 2005.
83. Erdal H, Berndtsson M, Castro J, Brunk UT, Shoshan MC and Linder S: Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 102: 192-197, 2005.
84. El-Rayes BF, Grignon R, Aslam N, Aranha O and Sarkar FH: Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells. Int J Oncol 21: 207-211, 2002.
85. Fehrenbacher N and Jäättela M: Lysosomes as targets for cancer therapy. Cancer Res 65: 2993-2995, 2005.